Publication:
Reply to Aydin et al: "To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease?"

Simple item page
dc.contributor.authorEREN, FATİH
dc.contributor.authorYILMAZ, YUSUF
dc.contributor.authorsYilmaz Y., Eren F.
dc.date.accessioned2022-03-15T01:58:48Z
dc.date.accessioned2026-01-11T19:05:16Z
dc.date.available2022-03-15T01:58:48Z
dc.date.issued2011
dc.description.abstract[No abstract available]
dc.identifier.doi10.1016/j.metabol.2011.03.001
dc.identifier.issn260495
dc.identifier.urihttps://hdl.handle.net/11424/247116
dc.language.isoeng
dc.relation.ispartofMetabolism: Clinical and Experimental
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleReply to Aydin et al: "To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease?"
dc.typeother
dc.type.subletter
dspace.entity.typePublication
oaire.citation.issue7
oaire.citation.titleMetabolism: Clinical and Experimental
oaire.citation.volume60

Files

Collections

Araştırma Çıktıları